ABBOTT LABORATORIES Income Tax Expense 2007-2026 | ABT
Beta
What is income tax expense?
Income tax expense is the total amount of income taxes a company owes to federal, state, and foreign governments.
What is ABBOTT LABORATORIES's current income tax expense?
ABBOTT LABORATORIES (ABT) annual income tax expense for 2025 was $1.94B, a 130.40% increase from 2024. ABBOTT LABORATORIES income tax expense for the quarter ending March 31, 2026 was $372.0M.
What was ABBOTT LABORATORIES's income tax expense in 2024?
ABBOTT LABORATORIES annual income tax expense for 2024 was $-6.39B, a 778.96% decline from 2023.
What was ABBOTT LABORATORIES's income tax expense in 2023?
ABBOTT LABORATORIES annual income tax expense for 2023 was $941.0M, a 31.46% decline from 2022.
What is ABBOTT LABORATORIES's 5-year income tax expense CAGR?
ABBOTT LABORATORIES income tax expense grew at a compound annual growth rate (CAGR) of 31.33% from FY2020 to FY2025, going from $497.0M to $1.94B over 5 years.
Income Tax Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+31.3%
FY2020
$497.0M
→
FY2025
$1.94B
07080910111213141516171819202122232425
5 years selected
Income Tax Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.94B | +130.4% | 10-K |
| FY2024 | $-6.39B | -779.0% | 10-K |
| FY2023 | $941.0M | -31.5% | 10-K |
| FY2022 | $1.37B | +20.4% | 10-K |
| FY2021 | $1.14B | +129.4% | 10-K |
| FY2020 | $497.0M | +27.4% | 10-K |
| FY2019 | $390.0M | -27.6% | 10-K |
| FY2018 | $539.0M | -71.3% | 10-K |
| FY2017 | $1.88B | +436.6% | 10-K |
| FY2016 | $350.0M | -39.3% | 10-K |
| FY2015 | $577.0M | -27.6% | 10-K |
| FY2014 | $797.0M | +1403.8% | 10-K |
| FY2013 | $53.0M | +111.6% | 10-K |
| FY2012 | $-457.0M | -515.5% | 10-K |
| FY2011 | $110.0M | -89.9% | 10-K |
| FY2010 | $1.09B | -25.0% | 10-K |
| FY2009 | $1.45B | +29.0% | 10-K |
| FY2008 | $1.12B | +30.0% | 10-K |
| FY2007 | $863.3M | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →